Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1974 May;29(3):317–322. doi: 10.1136/thx.29.3.317

An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction

With special reference to a β-2 stimulant—salmefamol

S Lal 1,2, C H Dash 1,2, M D Gribben 1,2
PMCID: PMC470152  PMID: 4850526

Abstract

Lal, S., Dash, C. H., and Gribben M. D. (1974).Thorax, 29, 317-322. An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction: with special reference to a β-2 stimulant—salmefamol. A method is described for comparing the bronchodilator effect of a large number of drugs. It involves self-recording of peak expiratory flow rate by patients at home. From the experience gained, the method was used to compare isoprenaline, orciprenaline, terbutaline, salbutamol, and salmefamol with an inert pressurized aerosol. The results of the comparison show that the method is simple and practical and that salmefamol would seem to have a more prolonged bronchodilator effect than the other drugs tested.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Choo-Kang Y. F., Simpson W. T., Grant I. W. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J. 1969 May 3;2(5652):287–289. doi: 10.1136/bmj.2.5652.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Formgren H. Clinical comparison of inhaled terbutaline and orciprenaline in asthmatic patients. Scand J Respir Dis. 1970;51(3):203–211. [PubMed] [Google Scholar]
  3. Freedman B. J. Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol. Br J Dis Chest. 1972 Jul;66(3):222–229. [PubMed] [Google Scholar]
  4. Hartley D., Jack D., Lunts L. H., Ritchie A. C. New class of selective stimulants of beta-adrenergic receptors. Nature. 1968 Aug 24;219(5156):861–862. doi: 10.1038/219861a0. [DOI] [PubMed] [Google Scholar]
  5. Kennedy M. C., Dash C. H. The bronchodilator effect of a new adrenergic aerosol--Salmefamol. Acta Allergol. 1972 Feb;27(1):22–26. doi: 10.1111/j.1398-9995.1972.tb01639.x. [DOI] [PubMed] [Google Scholar]
  6. LAL S., FERGUSON A. D., CAMPBELL E. J. FORCED EXPIRATORY TIME: A SIMPLE TEST FOR AIRWAYS OBSTRUCTION. Br Med J. 1964 Mar 28;1(5386):814–817. doi: 10.1136/bmj.1.5386.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Shenfield G. M., Paterson J. W. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 1973 Mar;28(2):124–128. doi: 10.1136/thx.28.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. WRIGHT B. M., McKERROW C. B. Maximum forced expiratory flow rate as a measure of ventilatory capacity: with a description of a new portable instrument for measuring it. Br Med J. 1959 Nov 21;2(5159):1041–1046. doi: 10.1136/bmj.2.5159.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES